PlainPill

Rapamycin

Also known as Sirolimus

The short answer. There isn't much data on Rapamycin yet — 61 mentions, 11 with a clear outcome — so treat these numbers as anecdotal. It is most often used for longevity: 100% of 7 reports say that improved. It is well studied — 497 meta-analyses on PubMed.

What users report
28%helped11 reports · few reports
3 helped6 mixed2 didn't help

From 61 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
497
meta-analyses
1,245
RCTs
52,431
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Rapamycin does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 497 meta-analyses on PubMed ↗ · 1,245 randomized trials ↗

Int J Oncol · 2021 · Meta-analysis / systematic review
Everolimus therapy and side‑effects: A systematic review and meta‑analysis

Conclusion: The majority of the patients reported adverse events limited to grade 1 or 2. On the whole, the data presented herein confirm the findings of previous studies on the relative safety of everolimus, a targeted therapeutic agent, which differs from that of conventional chemotherapy, and highlight the potential adverse events associated with the therapeutic use of everolimus.

PubMed 34132370 ↗
Int J Mol Sci · 2024 · Meta-analysis / systematic review
Cellular and Molecular Pathophysiology of Gestational Diabetes

Conclusion: GD's complex pathophysiology involves multiple disruptions in insulin signaling, mitochondrial function, inflammation, and oxidative stress. Effective management requires early detection, preventive strategies, and international collaboration to standardize care and improve outcomes for mothers and babies.

PubMed 39519193 ↗
Cochrane Database Syst Rev · 2019 · Meta-analysis / systematic review
Interventions for orbital lymphangioma

Conclusion: Currently, there are no published RCTs of orbital lymphangioma treatments. Without these types of studies, conclusions cannot be drawn regarding the effectiveness of the medical and surgical treatment options for patients with orbital lymphangiomas. The presence of only case reports and case series on orbital lymphangiomas makes it clear that RCTs are needed to address the differences between these options and help guide treatment plans. Such trials would ideally compare outcomes between individuals randomized to one of the following treatment options: observation, sclerotherapy, systemic siro

PubMed 31094450 ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “IMMUNOSUPPRESSION, USE IS NOT RECOMMENDED IN LIVER OR LUNG TRANSPLANT PATIENTS Increased susceptibility to infection and the possible development of lymphoma and other malignancies may result from immunosuppression Increased susceptibility to infection and the possible development of lymphoma may…”

Full label on DailyMed (NIH) ↗

FDA recalls

5 recalls of products named for Rapamycin. Most recent:

  • 2024-05-29 · Class III: Failed Impurities/Degradation Specifications record ↗
  • 2022-05-25 · Class III: Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint. record ↗
  • 2021-09-29 · Class III: Failed Impurities/Degradation Specifications record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

13,365 adverse-event reports mention Rapamycin. Most often reported:

  • Off label use · 2,055
  • Drug ineffective · 1,116
  • Product use in unapproved indication · 784
  • Pyrexia · 524
  • Diarrhoea · 514
  • Pneumonia · 487

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Rapamycin C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 137 research projects with Rapamycin in the title, $138,138,622 in total (1992–2026). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Sirolimus ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

fatigue ×1slow wound ×1canker sores ×1hyperglycemia ×1insulin resistance ×1slower hair ×1stomach issues ×1diarrhea ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I've noticed a 10% increase in HDL and some fatigue the day after taking more than 6mg.”
MixedRead the discussion ↗
“A month after Rapamycin, I dropped 9 lbs from 230 to 220.”
MixedRead the discussion ↗
“Rapamycin is used clinically to prevent organ rejection in transplant recipients. I would not recommend taking an immunosuppressant recreationally.”
MixedRead the discussion ↗
“My skin looks great, my metabolic profile is great, blood pressure is great”
MixedRead the discussion ↗
Read more Rapamycin reviews →
Top discussions (5)

Rapamycin compared

Other options for longevity

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate